Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$246M |
| 2 |
ExxonMobil
XOM
|
+$96.1M |
| 3 |
Apple
AAPL
|
+$62M |
| 4 |
Verizon
VZ
|
+$58.6M |
| 5 |
Boeing
BA
|
+$52.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$174M |
| 2 |
SE
Spectra Energy Corp Wi
SE
|
+$85.4M |
| 3 |
STJ
St Jude Medical
STJ
|
+$69M |
| 4 |
Caterpillar
CAT
|
+$63.8M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.76% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 12.7% |
| 4 | Industrials | 11.05% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Paychex
PAYX
$42.7B
| $85.2M | 0.09% |
1,446,224
+93,663
| +7% | +$5.69M |
|
|
STI
227
DELISTED
SunTrust Banks, Inc.
STI
| $85.1M | 0.09% |
1,539,109
+54,371
| +4% | +$3.12M |
|
228
Owens Corning
OC
$12.4B
| $84.9M | 0.09% |
1,383,533
+366,192
| +36% | +$21M |
|
|
ALXN
229
DELISTED
Alexion Pharmaceuticals
ALXN
| $84.6M | 0.08% |
697,913
+57,455
| +9% | +$7.41M |
|
|
HOLX
230
DELISTED
Hologic
HOLX
| $84.6M | 0.08% |
1,987,217
-462,869
| -19% | -$18.9M |
|
231
Constellation Brands
STZ
$23.2B
| $84.5M | 0.08% |
521,625
+16,268
| +3% | +$2.54M |
|
232
VF Corp
VFC
$5.89B
| $84.4M | 0.08% |
1,630,947
+546,128
| +50% | +$26.9M |
|
|
EA
233
DELISTED
Electronic Arts
EA
| $83.8M | 0.08% |
935,726
+67,066
| +8% | +$5.71M |
|
234
Baxter International
BAX
$14.2B
| $82.7M | 0.08% |
1,593,978
+56,170
| +4% | +$2.76M |
|
|
PPL
235
PPL Corp
PPL
$26.7B
| $82.6M | 0.08% |
2,209,916
+135,127
| +7% | +$4.83M |
|
236
Weyerhaeuser
WY
$18.4B
| $82M | 0.08% |
2,413,656
+108,763
| +5% | +$3.54M |
|
237
Ross Stores
ROST
$81.9B
| $81.7M | 0.08% |
1,240,033
+43,198
| +4% | +$2.89M |
|
238
Western Digital
WDC
$150B
| $81.6M | 0.08% |
1,308,223
+70,461
| +6% | +$4.05M |
|
|
K
239
DELISTED
Kellanova
K
| $81.2M | 0.08% |
1,191,161
+67,718
| +6% | +$4.67M |
|
|
AIV
240
Aimco
AIV
$383M
| $81.1M | 0.08% |
13,728,428
+2,574,511
| +23% | +$15.3M |
|
241
Zimmer Biomet
ZBH
$18.4B
| $80.9M | 0.08% |
682,219
+39,776
| +6% | +$4.51M |
|
242
Reinsurance Group of America
RGA
$16.1B
| $80.9M | 0.08% |
636,718
-598
| -0.1% | -$75.9K |
|
243
Vertex Pharmaceuticals
VRTX
$126B
| $80.8M | 0.08% |
738,549
+42,718
| +6% | +$3.76M |
|
244
Schwab International Equity ETF
SCHF
$68.7B
| $80.1M | 0.08% |
5,364,150
+615,026
| +13% | +$8.93M |
|
245
Tyson Foods
TSN
$20.4B
| $80M | 0.08% |
1,295,728
+57,504
| +5% | +$3.62M |
|
246
Zoetis
ZTS
$30B
| $79.8M | 0.08% |
1,494,632
+76,758
| +5% | +$4.15M |
|
|
DHC
247
Diversified Healthcare Trust
DHC
$2.14B
| $79.8M | 0.08% |
3,938,518
+1,083,063
| +38% | +$21.2M |
|
248
Everest Group
EG
$14.4B
| $79.6M | 0.08% |
340,418
+18,606
| +6% | +$4.25M |
|
249
Clorox
CLX
$12.7B
| $79.1M | 0.08% |
586,730
+23,243
| +4% | +$3.01M |
|
250
UGI
UGI
$7.33B
| $79.1M | 0.08% |
1,600,999
-370,332
| -19% | -$17.6M |
|
Similar funds
Charles Schwab's Q1 2017 Portfolio in Review
As of Q1 2017, Charles Schwab held 3,112 positions worth $99.9B, up 9.4% from $91.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $4.38B of net new capital in Q1 2017, opening 37 new positions and adding to 2,360 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Chevron, an estimated $174M trimmed.
- Charles Schwab's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
- Charles Schwab added most to Home Depot in Q1 2017, an estimated $246M increase.
- Charles Schwab's biggest Q1 2017 reduction was Chevron, cutting an estimated $174M.
- Charles Schwab fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $85.4M.
- Charles Schwab's ten largest holdings make up 14% of its $99.9B portfolio in Q1 2017.
- Charles Schwab opened 37 new positions and closed 57 in Q1 2017.
- Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $99.9B.
Based on Charles Schwab's 13F filing for Q1 2017, filed 15 May 2017.